|
|
 | | | |
- close
- close
- close
- close
Paladin Labs Inc (PLB) |
QUOTE AND NEWS
Marketwire
May 3
Comment
MONTREAL, CANADA -- (Marketwire) -- 05/03/12 -- Paladin Labs Inc. (TSX:PLB), a leading specialty pharmaceutical company, today reported its financial results for the quarter ended March 31, 2012. 2012 First Quarter Highlights Financial -- Revenues
Marketwire
Apr 26
Comment
MONTREAL, CANADA -- (Marketwire) -- 04/26/12 -- Paladin Labs Inc. (TSX:PLB), a leading Canadian specialty pharmaceutical company, will release its first quarter 2012 financial results on Thursday, May 3, 2012 prior to the market opening. Following
Marketwire
Mar 21
Comment
MONTREAL, CANADA -- (Marketwire) -- 03/21/12 -- Paladin Labs Inc. (TSX:PLB) announced today that Health Canada has approved Oralair(TM). Oralair(TM) is a sublingual grass pollen immunotherapy tablet for the treatment of the symptoms of moderate to
Marketwire
Feb 22
Comment
MONTREAL, CANADA and SAN DIEGO, CALIFORNIA -- (Marketwire) -- 02/22/12 -- Paladin Labs Inc. (TSX:PLB) and Somaxon Pharmaceuticals, Inc. (NASDAQ:SOMX) today announced that Paladin has filed a New Drug Submission (NDS) that has been accepted for review
Marketwire
Feb 21
Comment
MONTREAL, CANADA -- (Marketwire) -- 02/21/12 -- Paladin Labs Inc. (TSX:PLB), a leading Canadian specialty pharmaceutical company, announced today that Mark Beaudet, interim President & CEO will present a corporate update at the RBC Capital
Marketwire
Feb 21
Comment
MONTREAL, CANADA -- (Marketwire) -- 02/21/12 -- Paladin Labs Inc. (TSX:PLB) ("Paladin") today announced that it has entered into a strategic partnership whereby Paladin will accelerate its buy-out of the remaining 55.01% of Pharmaplan (Pty) Limited
Marketwire
Feb 16
Comment
MONTREAL, CANADA -- (Marketwire) -- 02/16/12 -- Paladin Labs Inc. (TSX:PLB), a leading Canadian specialty pharmaceutical company, today reported its financial results for the fourth quarter and year ended December 31, 2011. The Company has achieved
Marketwire
Feb 9
Comment
MONTREAL, CANADA -- (Marketwire) -- 02/09/12 -- Paladin Labs Inc. (TSX:PLB), a leading Canadian specialty pharmaceutical company, will release its fourth quarter 2011 financial results on Thursday, February 16, 2012 prior to market opening. Following
Marketwire
Nov 28
Comment
MONTREAL, CANADA -- (Marketwire) -- 11/28/11 -- Paladin Labs Inc. ("Paladin") (TSX:PLB), a leading Canadian specialty pharmaceutical company, today announced that it has entered into a licensing and distribution agreement with Immuron Limited
Marketwire
Nov 3
Comment
MONTREAL, CANADA -- (Marketwire) -- 11/03/11 -- Paladin Labs Inc. ("Paladin") (TSX:PLB), a leading Canadian specialty pharmaceutical company, today reported its third quarter 2011 financial results. 2011 Third Quarter Highlights -- Revenues reached a
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
